sur NEOVACS (EPA:ALNEV)
NEOVACS: Amendment to the trust agreement to optimize financing
On March 25, 2025, Neovacs announced an amendment to its trust agreement established in June 2023. This change aims to improve the terms of subscription to the straight bonds (SBDs) for optimized financing. The trust, initially created to convert and transfer the SBDs, has had its term extended to 2027 and its terms adjusted.
The outstanding ORAs will be replaced by SOs on March 31, 2025, allowing the trust to fund Neovacs through SO issuances at defined intervals. Amendments to the terms of the SOs are also planned to extend the funding period.
Warning: Investors should remain cautious as these dilutive financings could reduce the value of the shares and result in significant capital dilution.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NEOVACS